Kitayama S, Ikeda T, Mitsuhata C, Sato T, Morita K, Dohi T
Department of Pharmacology, Hiroshima University School of Dentistry, Kasumi 1-2-3, Minami-ku, Hiroshima 734, Japan.
J Biol Chem. 1999 Apr 16;274(16):10731-6. doi: 10.1074/jbc.274.16.10731.
We have cloned from rat brain a family of alternatively spliced cDNAs from a single gene, which encodes a norepinephrine transporter (NET) having variations at the 3'-region including both coding and noncoding regions. This produces two transporter isoforms, rNETa and rNETb, which differ at their COOH termini. The rNETa isoform reveals a COOH terminus homologous to human NET and transports norepinephrine. In contrast, rNETb revealed no detectable transport function but reduced functional expression of rNETa when both isoforms were expressed in the same cell. Thus, rNETb potentially functions as a dominant negative inhibitor of rNETa activity. Co-expression of rNETb with a gamma-aminobutyric acid transporter (rGAT1), a serotonin transporter (rSERT), and a dopamine transporter (rDAT) reduced their transport activity. No reduction was found with the glutamate/aspartate transporter (rGLAST). Alternative RNA splicing of NET suggests a novel mechanism for the regulation of synaptic transmission.
我们从大鼠脑中克隆了一个单一基因的可变剪接cDNA家族,该基因编码一种去甲肾上腺素转运体(NET),其3'区域包括编码区和非编码区都存在变异。这产生了两种转运体异构体,rNETa和rNETb,它们的COOH末端不同。rNETa异构体的COOH末端与人类NET同源,并能转运去甲肾上腺素。相比之下,rNETb没有可检测到的转运功能,但当两种异构体在同一细胞中表达时,会降低rNETa的功能表达。因此,rNETb可能作为rNETa活性的显性负性抑制剂发挥作用。rNETb与γ-氨基丁酸转运体(rGAT1)、5-羟色胺转运体(rSERT)和多巴胺转运体(rDAT)共表达会降低它们的转运活性。而谷氨酸/天冬氨酸转运体(rGLAST)则没有降低。NET的可变RNA剪接提示了一种调节突触传递的新机制。